The total return over the past 12 months is -9.74% vs. +16.94% for the S&P 500. So far it's up -5.45% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (9.74%) | (6.76%) | (8.26%) | (4.65%) | (2.01%) | (7.73%) |
| Total Return CAGR | (9.74%) | (6.76%) | (8.26%) | (4.65%) | (2.01%) | (7.73%) |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (777.78%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Anixa Biosciences, Inc. (ANIX)
| Year | Start price | End price | ANIX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.12 | $2.95 | (5.45%) | +14.51% | (19.96%) |
| 2025 | $2.32 | $3.12 | +34.48% | +17.72% | +16.76% |
| 2024 | $3.88 | $2.32 | (40.21%) | +24.89% | (65.10%) |
| 2023 | $4.25 | $3.88 | (8.71%) | +26.19% | (34.90%) |
| 2022 | $2.97 | $4.25 | +43.10% | (18.17%) | +61.27% |
| 2021 | $3.07 | $2.97 | (3.26%) | +28.74% | (32.00%) |
| 2020 | $3.28 | $3.07 | (6.40%) | +18.37% | (24.77%) |
| 2019 | $3.94 | $3.28 | (16.75%) | +31.22% | (47.97%) |
| 2018 | $2.36 | $3.94 | +66.95% | (4.56%) | +71.51% |
| 2017 | $5.40 | $2.36 | (56.30%) | +21.70% | (78.00%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
